Non-Small Cell Lung Cancer
Angiostatin phase II clinical trial underway
Published in Angiogenesis Weekly, August 30th, 2002
In this randomized clinical trial at Indiana University School of Medicine in Indianapolis, patients will self-inject a low dose or a high dose of Angiostatin under the skin twice daily. Concomitantly, Paclitaxel and carboplatin, considered standard chemotherapy for NSCLC, will be administered every 3 weeks via intravenous bolus administration for up to 18 weeks.
The trial...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Angiogenesis Weekly
Source: Angiogenesis Weekly (2002-08-30)
More Articles from Angiogenesis Weekly
- Breast Cancer
Enzyme produced by breast tumor cells an indicator for angiogenic induction - Cell Conditioning
Pretransplantation stimulus improves effects of bone marrow cell implants - Tumor Therapy
Treatments combining soluble receptors could be key to limiting tumor size - Appointments
Company announces executive management team, U.S. patents - Cancer Therapy
Photodynamic therapy gets a boost from COX-2 inhibitors - Non-Animal Proteins
ProdiGene begins scale-up of aprotinin from plants - More from this issue of Angiogenesis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
